2020
DOI: 10.1002/advs.202002026
|View full text |Cite
|
Sign up to set email alerts
|

Transcranial Ultrasound Innovations Ready for Broad Clinical Application

Abstract: Brain diseases are one of the most important problems in our rapidly ageing society. Currently, there are not many effective medications and surgical options are limited due to invasiveness and non-invasive brain stimulation techniques cannot be well targeted and cannot access deep brain areas. A novel therapy is transcranial ultrasound which allows a variety of treatments without opening of the skull. Recent technological developments generated three revolutionary options including 1) targeted non-invasive su… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
39
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

5
3

Authors

Journals

citations
Cited by 38 publications
(41 citation statements)
references
References 64 publications
0
39
0
Order By: Relevance
“…Thus, a large body of preclinical and clinical evidence suggests that the blood–brain barrier (BBB) opening by FUS can be done safely [ 54 , 55 ]. However, potential risks should be noted, including microbleeds, cellular vacuolation, ischemia due to vasoconstriction, cerebral edema, and direct cellular injury from physical forces, even at the typical low sound pressure [ 56 ]. Since most neuromodulation studies have been done without BBB opening and generated clear neurophysiologial effects, non-BBB opening ultrasound ("focused" and "unfocused") might be a safer therapeutic option.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, a large body of preclinical and clinical evidence suggests that the blood–brain barrier (BBB) opening by FUS can be done safely [ 54 , 55 ]. However, potential risks should be noted, including microbleeds, cellular vacuolation, ischemia due to vasoconstriction, cerebral edema, and direct cellular injury from physical forces, even at the typical low sound pressure [ 56 ]. Since most neuromodulation studies have been done without BBB opening and generated clear neurophysiologial effects, non-BBB opening ultrasound ("focused" and "unfocused") might be a safer therapeutic option.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, the novel therapeutic concept of ultrasound‐based brain stimulation has been introduced as a promising clinical add‐on therapy. 1 With navigated ultrasound techniques (focused ultrasound [FUS], transcranial pulse stimulation [TPS]) neuromodulation is no longer limited to superficial brain areas but allows 3D targeting of deep areas of the human brain. 2 The small ultrasound foci are independent from pathological conductivity changes and therefore brain areas can be targeted with unprecedented precision.…”
Section: Introductionmentioning
confidence: 99%
“…While the I SPPA for TPS lies within the FDA limits for cephalic use (I SPPA = 190 W/ cm 2 ), the I SPTA is marginally higher (I SPTA = 94 mW/cm 2 ) and the MI exceeds respective FDA limits (MI = 1.90) [26]. However, comprehensive animal studies exist for therapeutic ultrasound applications and have been used for the successful clinical certification process of TPS [13]. Indeed, TPS is clinically certified as therapy for Alzheimer's disease (CE mark).…”
Section: Transcranial Pulse Stimulation (Tps)mentioning
confidence: 99%
“…Recently, we introduced transcranial pulse stimulation (TPS) [11][12][13], a new NIBS technique that is based on single ultrashort ultrasound pulses (3 µs, repeated every 200-300 ms). With a lateral resolution comparable to tFUS, TPS allows a spatially distinct brain stimulation as well.…”
Section: Introductionmentioning
confidence: 99%